The Association between KIF6 Single Nucleotide Polymorphism rs20455 and Serum Lipids in Filipino-American Women
- PMID: 24587901
- PMCID: PMC3920675
- DOI: 10.1155/2014/328954
The Association between KIF6 Single Nucleotide Polymorphism rs20455 and Serum Lipids in Filipino-American Women
Abstract
The Trp719Arg allele of KIF6 rs20455, a putative risk factor for CHD especially in those with elevated low-density lipoprotein cholesterol (LDL-C), was investigated in Filipino-American women (FAW, n = 235) participating in health screenings in four cities. The rs20455 genotype of each subject was determined by a multiplex assay using a Luminex-OLA procedure. The risk allele Trp719Arg was present in 77% of the subjects. The genotype distribution was 23% Trp/Trp, 51% Arg/Trp, and 26% Arg/Arg. Genotype did not predict the presence of CHD risk factors. Moreover, LDL-C, HDL-C, and triglycerides mean values did not vary as a function of genotype. However, those with the Arg/Arg genotype on statin medication exhibited a significantly higher mean triglycerides level (P < 0.01). Approximately 60% of participants regardless of genotype exhibited LDL-C levels ≥100 mg/dL but were not taking medication. Approximately 43% of those with the Trp719Arg risk allele on statins exhibited elevated LDL-C levels. Our study suggests that the Trp719Arg allele of KIF 6 rs20455 is common among Filipino-American women; thus, even with borderline LDL-C levels would benefit from statin treatment. Secondly, many participants did not exhibit guideline recommended LDL-C levels including many who were on statin drugs.
Similar articles
-
Relationship between Lipid Phenotypes, Overweight, Lipid Lowering Drug Response and KIF6 and HMG-CoA Genotypes in a Subset of the Brisighella Heart Study Population.Int J Mol Sci. 2017 Dec 24;19(1):49. doi: 10.3390/ijms19010049. Int J Mol Sci. 2017. PMID: 29295555 Free PMC article.
-
Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease.BMC Med Genet. 2011 Mar 24;12:42. doi: 10.1186/1471-2350-12-42. BMC Med Genet. 2011. PMID: 21435211 Free PMC article.
-
No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.J Am Coll Cardiol. 2011 May 17;57(20):2000-7. doi: 10.1016/j.jacc.2011.02.015. Epub 2011 Mar 31. J Am Coll Cardiol. 2011. PMID: 21458191 Clinical Trial.
-
Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.Curr Diab Rep. 2019 Nov 21;19(12):146. doi: 10.1007/s11892-019-1246-y. Curr Diab Rep. 2019. PMID: 31754844 Review.
-
Lipoprotein(a), cardiovascular disease, and contemporary management.Mayo Clin Proc. 2013 Nov;88(11):1294-311. doi: 10.1016/j.mayocp.2013.09.003. Mayo Clin Proc. 2013. PMID: 24182706 Review.
Cited by
-
Relationship between Lipid Phenotypes, Overweight, Lipid Lowering Drug Response and KIF6 and HMG-CoA Genotypes in a Subset of the Brisighella Heart Study Population.Int J Mol Sci. 2017 Dec 24;19(1):49. doi: 10.3390/ijms19010049. Int J Mol Sci. 2017. PMID: 29295555 Free PMC article.
-
Genotyping and meta-analysis of KIF6 Trp719Arg polymorphism in South Indian Coronary Artery Disease patients: A case-control study.Meta Gene. 2015 Jul 15;5:129-34. doi: 10.1016/j.mgene.2015.07.001. eCollection 2015 Sep. Meta Gene. 2015. PMID: 26236646 Free PMC article.
-
Disease burden and the role of pharmacogenomics in African populations.Glob Health Epidemiol Genom. 2017 Feb 3;2:e1. doi: 10.1017/gheg.2016.21. eCollection 2017. Glob Health Epidemiol Genom. 2017. PMID: 29868213 Free PMC article. Review.
-
Novel KIF6 polymorphism increases susceptibility to type 2 diabetes mellitus and coronary heart disease in Han Chinese men.J Diabetes Res. 2014;2014:871439. doi: 10.1155/2014/871439. Epub 2014 Dec 31. J Diabetes Res. 2014. PMID: 25629058 Free PMC article.
References
-
- Cohen JC. Genetic approaches to coronary heart disease. Journal of the American College of Cardiology. 2006;48(9):A10–A14.
-
- Lusis AJ, Fogelman AM, Fonarow GC. Genetic basis of atherosclerosis: part II: clinical implications. Circulation. 2004;110(14):2066–2071. - PubMed
-
- Gibbons GH, Liew CC, Goodarzi MO, et al. Genetic markers: progress and potential for cardiovascular disease. Circulation. 2004;109(25, supplement 1):IV47–IV58. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources